Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to Insider Trades Newsletter so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email
LON:BNR

Burning Rock Biotech (BNR) Share Price, News & Analysis

→ Digitizing the $11T commodities sector with one tiny stock (From Resource Stock Digest) (Ad)
Free BNR Stock Alerts
GBX 8.05
-0.82 (-9.25%)
(As of 05/16/2024 05:38 PM ET)
Compare
Today's Range
8.05
▼
8.20
50-Day Range
0.84
▼
8.20
52-Week Range
7.69
▼
26.36
Volume
43 shs
Average Volume
45 shs
Market Capitalization
£8.51 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsHeadlines

About Burning Rock Biotech

Blenheim Natural Resources Plc invests in companies or assets in the natural resources and agribusiness sectors. It engages in establishing strategic and portfolio investments in listed and unlisted shares, as well as in projects in the natural resource sector covering the mining, oil and gas, and agricultural sectors. The company was formerly known as Coburg Group plc and changed its name to Blenheim Natural Resources Plc in September 2015. Blenheim Natural Resources Plc was incorporated in 1994 and is based in London, the United Kingdom.

BNR Stock Price History

BNR Stock News Headlines

May 18 at 10:16 PM | morningstar.com
Burning Rock Biotech Ltd ADR BNR
March 29, 2024 | finanznachrichten.de
Burning Rock Biotech Limited: Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results
December 1, 2023 | benzinga.com
Burning Rock Biotech Stock (NASDAQ:BNR) Insider Trades
December 1, 2023 | benzinga.com
Burning Rock Biotech Stock (NASDAQ:BNR) Dividends: History, Yield and Dates
October 31, 2023 | finance.yahoo.com
Burning Rock Biotech Limited's (NASDAQ:BNR) largest shareholders are individual investors with 29% ownership, institutions own 26%
October 15, 2023 | finance.yahoo.com
Burning Rock Received Breakthrough Device Designation from China’s NMPA for its Multi-Cancer Early Detection Test
August 31, 2023 | finanznachrichten.de
Burning Rock Biotech Limited: Burning Rock Reports Second Quarter 2023 Financial Results
August 3, 2023 | benzinga.com
Burning Rock Biotech Stock (NASDAQ:BNR), Quotes and News Summary
May 30, 2023 | finance.yahoo.com
Is Burning Rock Biotech (BNR) Outperforming Other Business Services Stocks This Year?
May 30, 2023 | finanznachrichten.de
Burning Rock Biotech Limited: Burning Rock Reports First Quarter 2023 Financial Results
May 30, 2023 | msn.com
Burning Rock Biotech GAAP EPS of -$0.26, revenue of $20.8M; reaffirms FY23 guidance
May 24, 2023 | finance.yahoo.com
While institutions own 25% of Burning Rock Biotech Limited (NASDAQ:BNR), private equity firms are its largest shareholders with 26% ownership
March 30, 2023 | finance.yahoo.com
Burning Rock Biotech Limited (NASDAQ:BNR) Q4 2022 Earnings Call Transcript
January 3, 2023 | finance.yahoo.com
Burning Rock Received FDA Breakthrough Device Designation for its OverC™ Multi-Cancer Detection Blood Test
December 23, 2022 | seekingalpha.com
Burning Rock Biotech Faces New COVID Wave
September 3, 2022 | lse.co.uk
Blenheim Natural Resources Share Chat
See More Headlines

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Diagnostic Imaging Centers
Sub-Industry
N/A
Current Symbol
LON:BNR
CUSIP
N/A
CIK
N/A
Web
www.blenheimnaturalresources.com
Phone
+44-1622-844601
Fax
N/A
Employees
2,020
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
105,725,000
Free Float
N/A
Market Cap
£8.51 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Charles Ainslie Wood (Age 43)
    Exec. Chairman
  • Marisa Iannetta
    Financial Controller

Key Competitors

View All Competitors

BNR Stock Analysis - Frequently Asked Questions

How have BNR shares performed in 2024?

Burning Rock Biotech's stock was trading at GBX 0.77 at the start of the year. Since then, BNR shares have increased by 946.8% and is now trading at GBX 8.05.
View the best growth stocks for 2024 here.

What other stocks do shareholders of Burning Rock Biotech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Burning Rock Biotech investors own include AbbVie (ABBV), BlackLine (BL), Bristol-Myers Squibb (BMY), Chipotle Mexican Grill (CMG), Ecolab (ECL), Gannett (GCI), Heron Therapeutics (HRTX), International Business Machines (IBM) and Lakeland Industries (LAKE).

How do I buy shares of Burning Rock Biotech?

Shares of BNR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:BNR) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
"The Biggest Drug Ever" Is Coming
Behind the Markets
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders
The 2024 Gold Rush: Unleashing Market Potential
Priority Gold
**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1!
Huge Alerts
Warren Buffett's "mystery stock"
Stansberry Research
This Could be Your “Big Money” AI Moment
InvestorPlace
Digitizing the $11T commodities sector with one tiny stock
Resource Stock Digest
Elon to Transform U.S. Economy?
Porter & Company